Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Asthma

  Free Subscription


Articles published in Ann Intern Med

Retrieve available abstracts of 16 articles:
HTML format



Single Articles


    December 2020
  1. WORSNOP CJ, McDonald CF
    Asthma self-management with regular support reduces health care use and improves QoL at 8 mo.
    Ann Intern Med. 2020;173:JC67.
    PubMed     Abstract available


    August 2020
  2. TARTOF SY, Qian L, Hong V, Wei R, et al
    Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization.
    Ann Intern Med. 2020 Aug 12. doi: 10.7326/M20-3742.
    PubMed     Abstract available


    March 2020
  3. SAHA BK, Modi A, Beegle S
    Asthma From Allergy to Titanium in a Cardiac Pacemaker.
    Ann Intern Med. 2020 Mar 31. pii: 2763875. doi: 10.7326/L19-0647.
    PubMed    


  4. STANBROOK MB
    In uncontrolled asthma, adding a LAMA to ICS plus LABA improved lung function at 6 mo and reduced exacerbations at 1 y.
    Ann Intern Med. 2020;172:JC28.
    PubMed    


    October 2019
  5. KING-BIGGS MB
    Asthma.
    Ann Intern Med. 2019;171:ITC49-ITC64.
    PubMed     Abstract available



  6. Correction: Omalizumab in Severe Allergic Asthma.
    Ann Intern Med. 2019;171:528.
    PubMed    


    March 2019
  7. MILGER K, Schroeder I, Behr J, Meis T, et al
    Omalizumab Rescue Therapy for Refractory Status Asthmaticus.
    Ann Intern Med. 2019;170:351-352.
    PubMed    


    November 2018
  8. PETERS JI, Maselli DJ
    Pooled RCTs: Adding LABAs to ICSs do not increase serious asthma events and reduce exacerbations.
    Ann Intern Med. 2018;169:JC53.
    PubMed    


    September 2018
  9. STANBROOK MB
    As-needed budesonide-formoterol better controlled mild asthma vs terbutaline, but maintenance budesonide was better.
    Ann Intern Med. 2018;169:JC31.
    PubMed    


  10. STANBROOK MB
    As-needed budesonide-formoterol was noninferior to maintenance budesonide for exacerbations in mild asthma.
    Ann Intern Med. 2018;169:JC30.
    PubMed    


    August 2018
  11. LEE J, McDonald C
    Review: Immunotherapy improves some symptoms and reduces long-term medication use in mild to moderate asthma.
    Ann Intern Med. 2018;169:JC17.
    PubMed    


    July 2018
  12. THIEN PF
    Review: SMART reduces asthma exacerbations compared with other controller and relief therapy regimens.
    Ann Intern Med. 2018;169:JC5.
    PubMed    


  13. THIEN PF
    Review: In uncontrolled, persistent asthma, adding LAMAs to inhaled corticosteroids reduce exacerbations.
    Ann Intern Med. 2018;169:JC4.
    PubMed    


    June 2018
  14. MASELLI DJ, Peters JI
    Quadrupling inhaled glucocorticoid dose for deteriorating asthma control reduced severe exacerbations.
    Ann Intern Med. 2018;168:JC65.
    PubMed    


    October 2017
  15. MASELLI DJ, Peters JI
    In severe asthma, benralizumab reduced daily oral glucocorticoid dose and asthma exacerbations at 6 months.
    Ann Intern Med. 2017;167:JC43.
    PubMed    


  16. STANBROOK MB
    Azithromycin reduced exacerbations and improved QoL in symptomatic asthma despite inhaled maintenance therapy.
    Ann Intern Med. 2017;167:JC42.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: